Growth funding OMS has secured multiple rounds of growth financing including £5 million from Salica Investments in 2026 and a Series A of $12.6M in 2024, signaling strong investor confidence and potential budget availability for expanded immersive training programs in healthcare institutions.

Strategic partnerships Recent collaboration with ASPiH to provide members access to OMS scenarios indicates a channel strategy that could be replicated with other health education networks, hospitals, and nursing associations to drive adoption and co-branded offerings.

Expansion momentum With a growing global footprint, AI-driven immersive training, and new generation OMS scenarios rolling out in 2025–2026, there is upside for health systems looking to modernize training, especially where VR/AI capabilities are prioritized.

Market validation Participation in major nursing and healthcare education events such as the NLN conference and engagement with academic institutions positions OMS as a credible solution for scalable clinical simulation across large networks.

Enterprise readiness OMS’s tech stack featuring Azure, Okta, and cloud optimization tools, along with enterprise-grade security like reCAPTCHA, supports selling to mid-market and large health systems seeking secure, scalable training platforms with potential integration into existing LMS and IT ecosystems.